Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04251182 |
|
Recruitment Status :
Recruiting
First Posted : January 31, 2020
Last Update Posted : June 3, 2022
|
Sponsor:
T3D Therapeutics, Inc.
Collaborators:
National Institute on Aging (NIA)
Clinilabs, Inc.
Alzheimer's Association
Information provided by (Responsible Party):
T3D Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | April 30, 2023 |
| Estimated Study Completion Date : | May 31, 2023 |